Skip to main content
Kerala Ayurveda Limited logo

Kerala Ayurveda Limited — Investor Relations & Filings

Ticker · 530163 ISIN · INE817B01025 LEI · 335800T6GJHTV8HHDP04 BSE.NS Human health and social work activities
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-25 Earnings Release
Country IN India
Listing BSE.NS 530163

About Kerala Ayurveda Limited

https://www.keralaayurveda.biz

Kerala Ayurveda Limited is a comprehensive Ayurvedic wellness entity with a heritage spanning over 75 years. The organization operates across the entire value chain of Ayurveda, including research, manufacturing, clinics, hospitals, wellness resorts, and educational academies. Its product portfolio comprises traditional herbal formulations, proprietary medicines, and wellness products developed through a seed-to-shelf approach. The company maintains a significant presence in both domestic and international markets, focusing on authentic Ayurvedic practices integrated with modern quality standards. Key services include specialized treatments for chronic conditions, rejuvenation therapies, and professional training programs. Kerala Ayurveda Limited emphasizes clinical research and standardized production processes to ensure the efficacy and safety of its traditional healing solutions.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 85% confidence The document is a standalone press‐style release dated 25th May 2026 that summarizes full‐year FY26 financial results (revenue, EBITDA, PBT, PAT), segment performance, outlook for FY27, and operational highlights, with forward‐looking guidance and a safe‐harbor statement. It is not a full Annual Report (10‐K), nor a board change, proxy, or regulatory certification. It presents initial financial results and guidance, matching the definition of an Earnings Release (ER). FY 2026
2026-05-25 English
Appointment of Internal Auditor and Cost Auditor
Interim / Quarterly Report Classification · 88% confidence The document is a stock-exchange filing under SEBI LODR Reg. 33/30, disclosing the audited standalone financial results for the quarter and full year ended March 31, 2026, with detailed tables and the auditor’s report. It contains actual financial statements (not just highlights), so it is not an Earnings Release (ER) but a full financial report for a period shorter than a fiscal year (quarterly results) and thus fits the Interim/Quarterly Report category (IR). FY 2026
2026-05-25 English
Financial Results for the Year Ended 31st March 2026
Regulatory Filings Classification · 80% confidence The document is a statutory disclosure to the Bombay Stock Exchange under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 33 and 30). It announces the outcome of a board meeting approving audited standalone and consolidated results for the quarter and full year ended March 31, 2026, attaches the unmodified audit report, and includes the full audited financial results statement. This is a mandatory regulatory announcement rather than a full Annual Report (10-K) or a typical interim/quarterly report (IR) filing itself. It is not merely a link or notice of report publication (RPA) nor an officer certification (RNS LODR certifications fall under RNS), but a compliance filing under SEBI Listing Regulations. As such, it best fits the “Regulatory Filings” category (RNS).
2026-05-25 English
Outcome of Board meeting held on 25th May 2026
Audit Report / Information Classification · 85% confidence The document is a formal listing‐compliance filing to the Bombay Stock Exchange under SEBI LODR Reg.33/30. After the board meeting notice and declaration, it includes the Statutory Auditor’s Independent Auditors’ Report on the audited standalone financial results (quarter and year‐to‐date) for the period ended March 31, 2026, complete with the auditor’s opinion, basis for opinion, emphasis of matter, and the full tables of results. This is precisely a standalone audit report on the company’s financial results (not a full annual report or mere earnings highlights). According to our taxonomy, this falls under Audit Report / Information (Code: AR).
2026-05-25 English
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Board meeting on 25th May 2026
Regulatory Filings Classification · 85% confidence The document is a regulatory notice filed under SEBI Listing Regulations informing the stock exchange of a forthcoming Board of Directors meeting to consider and approve audited financial results. It does not contain any financial statements or results itself, nor does it announce director changes, dividends, or shareholder votes. It is a general compliance/filing announcement (Board meeting intimation), so it falls into the fallback category “Regulatory Filings (RNS).”
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.